91 reports

Abstract: - Global Cancer Immunotherapy Market to Reach $123.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cancer Immunotherapy estimated at US$70.9 Billion in the year 2020, is projected to reach a revised size of US$123.9 Billion by 2027, growing at a CAGR of 8.3% over the analysis period 2020-2027....

  • Cancer Immunotherapy
  • World
  • China
  • United States

Cancer Immunotherapy Market Report Overview Cancer Immunotherapy market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Cancer Immunotherapy market types and applications. It is a focused study on Cancer Immunotherapy market space including...

  • Cancer Immunotherapy
  • World
  • Health Provider Density

Abstract: - Global Cancer Immunotherapy Drug Discovery Outsourcing Market to Reach $2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cancer Immunotherapy Drug Discovery Outsourcing estimated at US$879.3 Million in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing...

  • Cancer Immunotherapy
  • World
  • China
  • United States

Antibody Drug Conjugates (ADCs), Bispecific Monoclonal  Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric  Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors,  Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT)  & IDO Inhibitors  Within...

  • Cancer Immunotherapy
  • Immunotherapy
  • Therapy
  • World

Within the cancer therapeutics space, which today is worth over $100 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that have high specificity for cancer cells. Today, cancer immunotherapy drugs have captured nearly 50% of the overall oncology drugs market, generating...

  • Cancer Immunotherapy
  • World

"Global Cancer Immunotherapy Market Opportunity, Dosage, Price & Clinical Trials Insight 2026" Report Highlights: • Global Cancer Immunotherapy Market Opportunity: > US$ 200 Billion  • Cancer Immunotherapy Clinical Trials: > 2300 Drugs In Trials • Commercially Available Cancer Immunotherapies: >...

  • Cancer Immunotherapy
  • World

GLOBAL CANCER IMMUNOTHERAPY

  • Cancer
  • Cancer Immunotherapy
  • Therapy
  • Pharmaceutical
  • Indiana
  • Cancer Incidence
  • Cancer Mortality

Monoclonal Antibodies, Cytokines & Immunomodulators, Immune Checkpoint Inhibitors, Cell Therapy, Oncolytic Virus Immunotherapy, Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, Hospitals, Cancer Research Centres, Clinics The world cancer immunotherapy market is expected to...

  • Cancer Immunotherapy
  • World
  • APAC

Cancer Immunotherapy Market Analysis Report By Product (Oncolytic Viral Therapies & Cancer Vaccines, Monoclonal Antibodies, Immunomodulators), By Cancer Type (Breast, Lung), and Segment Forecasts, 2019 - 2026 The global cancer immunotherapy market size is likely to reach USD 126.9 billion by 2026, exhibiting a CAGR...

  • Cancer
  • Cancer Immunotherapy
  • Monoclonal Antibody
  • World
  • Cancer Incidence

The Global Cancer Immunotherapy Market size is expected to reach $128.3 billion by 2024, rising at a market growth of 14.3% CAGR during the forecast period. Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody,...

  • Cancer Immunotherapy
  • World
  • APAC
  • Health Expenditure

Global Cancer Immunotherapy Market to Reach $170.70 billion by 2028 The healthcare industry is a multi-billion-dollar market consisting of various verticals aimed at improving patient lives.The industry has experienced considerable advancement in terms of diagnosis and treatment, yet cancer remains as one of the leading...

  • Oncology
  • Cancer Immunotherapy
  • Cancer
  • World

Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis Report By Drug, By Service, By Cancer Type (Lung, Breast, Colorectal, Melanoma, Prostate, Pancreatic), And Segment Forecasts, 2018 - 2025 The global cancer immunotherapy drug discovery outsourcing market size is projected to reach USD 1.7Billion by 2025,...

  • Cancer Immunotherapy
  • World
  • Cancer Incidence

This report offers an eight year forecast on the global immune repertoire sequencing market. The primary objective of the report is to offer updates and information related to the opportunities in the immune repertoire sequencing market. Report Description In terms of revenue, the global immune repertoire sequencing...

  • Pharmaceutical
  • Genome Sequencing
  • Cancer Immunotherapy
  • Research Center
  • Diagnostics
  • World

The Europe Cancer Immunotherapy Market would witness market growth of 13.5 % CAGR during the forecast period (2018 – 2024). Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody, therapeutic cancer vaccines, checkpoint...

  • Cancer Immunotherapy
  • Europe
  • World
  • Health Expenditure

The Asia Pacific Market would witness market growth of 16.5% CAGR during the forecast period (2018 – 2024). Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody, therapeutic cancer vaccines, checkpoint inhibitors,...

  • Cancer Immunotherapy
  • APAC
  • Health Expenditure

The North America Cancer Immunotherapy Market would witness market growth of 13.1% CAGR during the forecast period (2018 – 2024). Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody, therapeutic cancer vaccines,...

  • Cancer Immunotherapy
  • North America
  • World
  • Health Expenditure

The Latin America, Middle East and Africa Cancer Immunotherapy Market would witness market growth of 15.5% CAGR during the forecast period (2018 – 2024). Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody, therapeutic...

  • Cancer Immunotherapy
  • World
  • Middle East
  • Latin America
  • Africa
  • Health Expenditure

Report Scope: Finding the right career path is one of the biggest challenges in every person’s life.We want to make sure we make the right choices and decisions concerning our future employment opportunities. And it’s no longer a one-time decision. Employment conditions and opportunities are not constantly evolving...

  • Immunotherapy
  • Monoclonal Antibody
  • Drug Development
  • Biotechnology
  • Cancer Immunotherapy
  • World

The Global Cancer Vaccine Partnering Terms and Agreements 2010-2020 report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer vaccine partnering deals Disclosed headlines, upfronts, milestones and royalties...

  • Cancer Immunotherapy
  • World

Monoclonal Antibodies, Cytokines & Immunomodulators, Immune Checkpoint Inhibitors, Cell Therapy, Oncolytic Virus Immunotherapy, Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer Report Details The world cancer immunotherapy market is expected to grow...

  • Cancer Immunotherapy
  • World
  • APAC

Global CTLA4 (Cytotoxic T-Lymphocyte-Alymphocyte-associated Protein 4) Inhibitors Market: About this market This CTLA4 (Cytotoxic T-Lymphocyte-Alymphocyte-associated Protein 4) inhibitors market analysis considers sales from both monotherapy and combination therapy . Our analysis also considers the sales of CTLA4 (Cytotoxic...

  • Cancer Immunotherapy
  • Immunotherapy
  • Lung Cancer
  • World

This study covers the world outlook for cancer immunotherapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Cancer Immunotherapy
  • World
  • Gross Domestic Product
  • Disposable Income

Global PD-1/PD-L1 Immunotherapy Market to Reach $71,097.9 Million by 2030 Market Report Coverage - Global PD-1/PD-L1 Immunotherapy Market Segmentation • Type: PD-1 and PD-L1 inhibitors • Application: Non-Small Cell Lung Cancer, Esophageal Cancer, Urothelial Carcinoma, Hepatocellular...

  • Cancer Immunotherapy
  • World
  • APAC
  • Disposable Income

China Platinum Sales Rural Population Hormone Cancer Immunotherapy Anti-Infective

  • Cancer
  • Cancer Immunotherapy
  • China
  • Industrial Production
  • Labour Force

Parker Institute for Cancer Immunotherapy (Parker Institute), a subsidiary of The Parker Foundation is a nonprofit public benefit corporation which focuses on the development of immune therapies for the treatment of cancer.

  • Cancer Immunotherapy
  • United States
  • California
  • Prescription Drug Sales

Listeria monocytogenes, a Gram-positive optional anaerobic bacterium, is becoming a common cancer immunotherapy vector.

  • Cancer Immunotherapy
  • Europe
  • Cancer Incidence
  • Cancer Mortality

World Cancer Immunotherapy

  • Cancer Immunotherapy
  • APAC
  • Europe
  • Africa
  • South Africa
  • Cancer Incidence
  • Cause-Specific Mortality Rate

Listeria monocytogenes, a Gram-positive optional anaerobic bacterium, is becoming a common cancer immunotherapy vector.

  • Cancer Immunotherapy
  • World
  • Middle East
  • Africa
  • Saudi Arabia
  • South Africa
  • United Arab Emirates
  • Cancer Incidence
  • Health Expenditure

Listeria monocytogenes, a Gram-positive optional anaerobic bacterium, is becoming a common cancer immunotherapy vector.

  • Cancer Immunotherapy
  • South America
  • Central America
  • Brazil
  • Cancer Incidence
  • Mortality Rate

Listeria monocytogenes, a Gram-positive optional anaerobic bacterium, is becoming a common cancer immunotherapy vector.

  • Cancer Immunotherapy
  • World
  • North America
  • United States
  • Cancer Incidence
  • Drug Approval